Persistent Atrial Myopathy Despite Ventricular Recovery: Prognostic Significance of Discordant LV-LA Strain Patterns in HFrEF.

IF 10.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Jiesuck Park, Nan Young Bae, Jaehyun Lim, Soongu Kwak, MinJung Bak, Hong-Mi Choi, Jun-Bean Park, Yeonyee E Yoon, Seung-Pyo Lee, Yong-Jin Kim, Goo-Yeong Cho, Hyung-Kwan Kim, In-Chang Hwang
{"title":"Persistent Atrial Myopathy Despite Ventricular Recovery: Prognostic Significance of Discordant LV-LA Strain Patterns in HFrEF.","authors":"Jiesuck Park, Nan Young Bae, Jaehyun Lim, Soongu Kwak, MinJung Bak, Hong-Mi Choi, Jun-Bean Park, Yeonyee E Yoon, Seung-Pyo Lee, Yong-Jin Kim, Goo-Yeong Cho, Hyung-Kwan Kim, In-Chang Hwang","doi":"10.1093/ejhf/xuag266","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Assessment of treatment response in HFrEF has largely relied on left ventricular (LV)-centric parameters, yet the left atrium (LA) modulates LV filling and reflects the cumulative hemodynamic burden. Whether discordant recovery between LV and LA function carries distinct prognostic implications in patients treated with ARNI-based therapy remains unknown.</p><p><strong>Methods and results: </strong>From the multicentre STRATS-HF-ARNI registry, 1,182 patients with HFrEF who underwent serial echocardiography at baseline and one-year follow-up were included. Patients were classified according to the change in LVGLS and LASr at one year: Group A, concordant recovery (57.4%); Group B, discordant atrial non-recovery (11.2%); Group C, discordant ventricular non-recovery (15.6%); and Group D, concordant non-recovery (16.0%). Outcomes included all-cause mortality, cardiovascular mortality, and HF hospitalization. Despite achieving LV functional improvement, Group B exhibited persistent LASr deterioration, accompanied by less favourable hemodynamic trajectories than Group A. On multivariable Cox regression, Group B had significantly higher risks of all-cause mortality (adjusted hazard ratio [aHR] 3.53, 95% confidence interval [CI] 1.60-7.79) and cardiovascular mortality (aHR 5.68, 95% CI 1.91-16.92), comparable to Group D. Group C demonstrated higher HF hospitalization risk (aHR 2.25, 95% CI 1.31-3.86). The adverse prognostic impact of discordant atrial non-recovery was consistently observed across subgroups stratified by baseline LVGLS and LASr levels.</p><p><strong>Conclusion: </strong>In HFrEF patients treated with ARNI-based therapy, persistent LA dysfunction despite LV functional improvement identifies a high-risk phenotype comparable to concordant non-recovery. These findings suggest that concurrent assessment of LV and LA strain may provide incremental prognostic value beyond LV-centric metrics alone.</p>","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":" ","pages":""},"PeriodicalIF":10.3000,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejhf/xuag266","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Assessment of treatment response in HFrEF has largely relied on left ventricular (LV)-centric parameters, yet the left atrium (LA) modulates LV filling and reflects the cumulative hemodynamic burden. Whether discordant recovery between LV and LA function carries distinct prognostic implications in patients treated with ARNI-based therapy remains unknown.

Methods and results: From the multicentre STRATS-HF-ARNI registry, 1,182 patients with HFrEF who underwent serial echocardiography at baseline and one-year follow-up were included. Patients were classified according to the change in LVGLS and LASr at one year: Group A, concordant recovery (57.4%); Group B, discordant atrial non-recovery (11.2%); Group C, discordant ventricular non-recovery (15.6%); and Group D, concordant non-recovery (16.0%). Outcomes included all-cause mortality, cardiovascular mortality, and HF hospitalization. Despite achieving LV functional improvement, Group B exhibited persistent LASr deterioration, accompanied by less favourable hemodynamic trajectories than Group A. On multivariable Cox regression, Group B had significantly higher risks of all-cause mortality (adjusted hazard ratio [aHR] 3.53, 95% confidence interval [CI] 1.60-7.79) and cardiovascular mortality (aHR 5.68, 95% CI 1.91-16.92), comparable to Group D. Group C demonstrated higher HF hospitalization risk (aHR 2.25, 95% CI 1.31-3.86). The adverse prognostic impact of discordant atrial non-recovery was consistently observed across subgroups stratified by baseline LVGLS and LASr levels.

Conclusion: In HFrEF patients treated with ARNI-based therapy, persistent LA dysfunction despite LV functional improvement identifies a high-risk phenotype comparable to concordant non-recovery. These findings suggest that concurrent assessment of LV and LA strain may provide incremental prognostic value beyond LV-centric metrics alone.

心室恢复后的持续性房肌病:HFrEF中不一致的LV-LA应变模式的预后意义。
目的:HFrEF治疗反应的评估主要依赖于左室(LV)中心参数,然而左心房(LA)调节左室充盈并反映累积血流动力学负担。在接受arni治疗的患者中,左室和左室功能的不一致恢复是否具有明显的预后意义尚不清楚。方法和结果:从多中心的STRATS-HF-ARNI注册表中,纳入了1182例HFrEF患者,他们在基线和一年随访时接受了连续超声心动图检查。根据1年LVGLS和LASr的变化将患者分为:A组,恢复一致(57.4%);B组:心房不协调不恢复(11.2%);C组:心室不协调不恢复(15.6%);D组一致不恢复(16.0%)。结果包括全因死亡率、心血管死亡率和心衰住院率。在多变量Cox回归分析中,B组的全因死亡率(校正风险比[aHR] 3.53, 95%可信区间[CI] 1.60-7.79)和心血管死亡率(aHR 5.68, 95% CI 1.91-16.92)明显高于d组。C组的HF住院风险较高(aHR 2.25, 95% CI 1.31-3.86)。在以基线LVGLS和LASr水平分层的亚组中,不一致的心房不恢复对预后的不良影响是一致的。结论:在接受arni治疗的HFrEF患者中,尽管左室功能改善,但持续的左室功能障碍确定了与一致性不恢复相当的高风险表型。这些发现表明,同时评估左室和左室毒株可能比单独以左室为中心的指标提供更多的预后价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Heart Failure
European Journal of Heart Failure 医学-心血管系统
CiteScore
27.30
自引率
11.50%
发文量
365
审稿时长
1 months
期刊介绍: European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书